1. Home
  2. MRUS vs NSP Comparison

MRUS vs NSP Comparison

Compare MRUS & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • NSP
  • Stock Information
  • Founded
  • MRUS 2003
  • NSP 1986
  • Country
  • MRUS Netherlands
  • NSP United States
  • Employees
  • MRUS N/A
  • NSP N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • NSP Professional Services
  • Sector
  • MRUS Health Care
  • NSP Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • NSP Nasdaq
  • Market Cap
  • MRUS 2.8B
  • NSP 2.6B
  • IPO Year
  • MRUS 2016
  • NSP 1997
  • Fundamental
  • Price
  • MRUS $47.37
  • NSP $84.90
  • Analyst Decision
  • MRUS Strong Buy
  • NSP Hold
  • Analyst Count
  • MRUS 13
  • NSP 4
  • Target Price
  • MRUS $85.67
  • NSP $95.67
  • AVG Volume (30 Days)
  • MRUS 513.2K
  • NSP 471.3K
  • Earning Date
  • MRUS 02-26-2025
  • NSP 02-10-2025
  • Dividend Yield
  • MRUS N/A
  • NSP 2.83%
  • EPS Growth
  • MRUS N/A
  • NSP N/A
  • EPS
  • MRUS N/A
  • NSP 2.39
  • Revenue
  • MRUS $35,932,000.00
  • NSP $6,581,000,000.00
  • Revenue This Year
  • MRUS N/A
  • NSP $5.91
  • Revenue Next Year
  • MRUS $42.15
  • NSP $7.79
  • P/E Ratio
  • MRUS N/A
  • NSP $35.45
  • Revenue Growth
  • MRUS N/A
  • NSP 1.46
  • 52 Week Low
  • MRUS $37.77
  • NSP $68.79
  • 52 Week High
  • MRUS $61.61
  • NSP $110.72
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 71.36
  • NSP 58.80
  • Support Level
  • MRUS $39.67
  • NSP $85.48
  • Resistance Level
  • MRUS $41.15
  • NSP $88.19
  • Average True Range (ATR)
  • MRUS 1.71
  • NSP 3.30
  • MACD
  • MRUS 0.86
  • NSP 0.92
  • Stochastic Oscillator
  • MRUS 91.57
  • NSP 83.04

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: